MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517064696 A) filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd., Zhejiang, China, on July 7, for 'salt-type glp-1 receptor agonist, crystal form thereof, preparation method therefor, pharmaceutical composition thereof, and use thereof.'

Inventor(s) include Zhai, Wenqiang; Tan, Fang; Han, Min; Pan, Hao; and Liu, Dongzhou.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "Disclosed are a salt-type GLP-1 receptor agonist, a crystal form thereof, a preparation method therefor, a pharmaceutical composition thereof, and the use thereof. Specif...